Leukaemia in Nagasaki atomic bomb survivors from 1945 through 1959
- PMID: 13921808
- PMCID: PMC2555781
Leukaemia in Nagasaki atomic bomb survivors from 1945 through 1959
Abstract
This review of the Nagasaki leukaemia experience during a period of 14 years after the detonation of the atomic bomb, together with comparisons with data from Hiroshima and from other series of post-radiation leukaemia cases, again demonstrates beyond reasonable doubt the leukaemogenic effect on man of ionizing radiation. An increased risk of leukaemia following doses probably as low as 100 rads (air-entry dose) of whole-body radiation is demonstrated on the basis of the available estimates of atomic bomb radiation doses. At doses above this level the increase in leukaemia incidence may be linearly related to the radiation dose. The data are too limited to allow of an evaluation of the risk represented by doses at the lower levels of radiation; but it seems clear that, if a threshold dose for leukaemia induction exists, it is lower than the threshold dose for the clinical expression of acute radiation syndrome.The sex and age distribution of radiation-induced leukaemia and the types of leukaemia observed are also discussed.
Similar articles
-
Cancer and non-cancer effects in Japanese atomic bomb survivors.J Radiol Prot. 2009 Jun;29(2A):A43-59. doi: 10.1088/0952-4746/29/2A/S04. Epub 2009 May 19. J Radiol Prot. 2009. PMID: 19454804 Review.
-
Leukaemia following childhood radiation exposure in the Japanese atomic bomb survivors and in medically exposed groups.Radiat Prot Dosimetry. 2008;132(2):156-65. doi: 10.1093/rpd/ncn264. Epub 2008 Oct 20. Radiat Prot Dosimetry. 2008. PMID: 18936088
-
Thyroid Dysfunction and Autoimmune Thyroid Diseases Among Atomic Bomb Survivors Exposed in Childhood.J Clin Endocrinol Metab. 2017 Jul 1;102(7):2516-2524. doi: 10.1210/jc.2017-00102. J Clin Endocrinol Metab. 2017. PMID: 28472357
-
Absence of evidence for differences in the dose-response for cancer and non-cancer endpoints by acute injury status in the Japanese atomic-bomb survivors.Int J Radiat Biol. 2002 Nov;78(11):1001-10. doi: 10.1080/0955300021000013803. Int J Radiat Biol. 2002. PMID: 12456287
-
Studies on the Hiroshima and Nagasaki survivors, and their use in estimating radiation risks.Radiat Prot Dosimetry. 2003;104(4):331-5. doi: 10.1093/oxfordjournals.rpd.a006196. Radiat Prot Dosimetry. 2003. PMID: 14579889 Review.
Cited by
-
Radiation-induced myeloid leukemia in murine models.Hum Genomics. 2014 Jul 25;8(1):13. doi: 10.1186/1479-7364-8-13. Hum Genomics. 2014. PMID: 25062865 Free PMC article. Review.
-
Mouse models for efficacy testing of agents against radiation carcinogenesis—a literature review.Int J Environ Res Public Health. 2012 Dec 27;10(1):107-43. doi: 10.3390/ijerph10010107. Int J Environ Res Public Health. 2012. PMID: 23271302 Free PMC article. Review.
-
A Destroyer of Tissues: A Case of Chronic Low-Dose Radiation Exposure and the Need for Frequent Screening in Exposed Populations.Cureus. 2024 Nov 1;16(11):e72845. doi: 10.7759/cureus.72845. eCollection 2024 Nov. Cureus. 2024. PMID: 39618768 Free PMC article.
-
A Critical Review of Animal Models Used in Acute Myeloid Leukemia Pathophysiology.Genes (Basel). 2019 Aug 13;10(8):614. doi: 10.3390/genes10080614. Genes (Basel). 2019. PMID: 31412687 Free PMC article. Review.
-
Mouse models for radiation-induced cancers.Mutagenesis. 2016 Sep;31(5):491-509. doi: 10.1093/mutage/gew019. Epub 2016 May 21. Mutagenesis. 2016. PMID: 27209205 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources